But but but I thought it wasn’t an antiviral (note it’s also an anti-inflammatory drug)? This is the "gold standard" trial that fauci claimed he and others are waiting for. So, who at the FDA and the rest of the NIH will be the first to admit it works? Who will be held accountable for all the needless suffering and death? Docs on the front lines have known for over 1.5 yrs that it works.
Current reuters article:
www.reuters.com
Reuters before they changed the headline:
Clinical trial info:
clinicaltrials.gov
There's also ample research going back to at least 2017 showing that it has not only antiviral but also anti-inflammatory effects. These are 2 of the 3 main phases with covid19 disease (the 3rd is blood clotting) so why in the eff wasn't Ivermectin (and also HCQ) the first thing suggested by the NIH to help fight this disease (this is rhetorical, it's b/c they are captured by big pharma)? An off patent drug that has an impeccable safety profile that has antiviral and ant inflammatory impacts, its perfect to be repurposed! Instead they actively discouraged it's use to rely instead on the novel vaccines (that some folks in the NIH happen to have patents on) which have ZERO long term safety data in humans.
www.nature.com
"Antiviral (e.g. HIV, dengue, encephalitis)
Recent research has confounded the belief, held for most of the past 40 years, that ivermectin was devoid of any antiviral characteristics. Ivermectin has been found to potently inhibit replication of the yellow fever virus, with EC50 values in the sub-nanomolar range. It also inhibits replication in several other flaviviruses, including dengue, Japanese encephalitis and tick-borne encephalitis, probably by targeting non-structural 3 helicase activity.97 Ivermectin inhibits dengue viruses and interrupts virus replication, bestowing protection against infection with all distinct virus serotypes, and has unexplored potential as a dengue antiviral.98
Ivermectin has also been demonstrated to be a potent broad-spectrum specific inhibitor of importin α/β-mediated nuclear transport and demonstrates antiviral activity against several RNA viruses by blocking the nuclear trafficking of viral proteins. It has been shown to have potent antiviral action against HIV-1 and dengue viruses, both of which are dependent on the importin protein superfamily for several key cellular processes. Ivermectin may be of import in disrupting HIV-1 integrase in HIV-1 as well as NS-5 (non-structural protein 5) polymerase in dengue viruses.99, 100..."
Current reuters article:
Ivermectin shows ‘antiviral effect’ against COVID, Japanese company says
Japanese trading and pharmaceuticals company Kowa Co Ltd on Monday said that anti-parasite drug ivermectin showed an "antiviral effect" against Omicron and other coronavirus variants in joint non-clinical research.
Reuters before they changed the headline:
Clinical trial info:
ClinicalTrials.gov
clinicaltrials.gov
There's also ample research going back to at least 2017 showing that it has not only antiviral but also anti-inflammatory effects. These are 2 of the 3 main phases with covid19 disease (the 3rd is blood clotting) so why in the eff wasn't Ivermectin (and also HCQ) the first thing suggested by the NIH to help fight this disease (this is rhetorical, it's b/c they are captured by big pharma)? An off patent drug that has an impeccable safety profile that has antiviral and ant inflammatory impacts, its perfect to be repurposed! Instead they actively discouraged it's use to rely instead on the novel vaccines (that some folks in the NIH happen to have patents on) which have ZERO long term safety data in humans.
Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations - The Journal of Antibiotics
Over the past decade, the global scientific community have begun to recognize the unmatched value of an extraordinary drug, ivermectin, that originates from a single microbe unearthed from soil in Japan. Work on ivermectin has seen its discoverer, Satoshi Ōmura, of Tokyo’s prestigious Kitasato...
www.nature.com
"Antiviral (e.g. HIV, dengue, encephalitis)
Recent research has confounded the belief, held for most of the past 40 years, that ivermectin was devoid of any antiviral characteristics. Ivermectin has been found to potently inhibit replication of the yellow fever virus, with EC50 values in the sub-nanomolar range. It also inhibits replication in several other flaviviruses, including dengue, Japanese encephalitis and tick-borne encephalitis, probably by targeting non-structural 3 helicase activity.97 Ivermectin inhibits dengue viruses and interrupts virus replication, bestowing protection against infection with all distinct virus serotypes, and has unexplored potential as a dengue antiviral.98
Ivermectin has also been demonstrated to be a potent broad-spectrum specific inhibitor of importin α/β-mediated nuclear transport and demonstrates antiviral activity against several RNA viruses by blocking the nuclear trafficking of viral proteins. It has been shown to have potent antiviral action against HIV-1 and dengue viruses, both of which are dependent on the importin protein superfamily for several key cellular processes. Ivermectin may be of import in disrupting HIV-1 integrase in HIV-1 as well as NS-5 (non-structural protein 5) polymerase in dengue viruses.99, 100..."
Last edited:
